Comment by redlollipop

If you read the article, the "complexity" refers to the lack of translation from bench to clinic. IP is the fundamental currency to attract investment to get scientific discoveries through the regulatory process. You can still have "open science" in the sense you are using this term and have patents; see CRISPR/Cas9 as a prime example.